To build manufacturing facilities for cancer drugs in Japan, the U.S., Germany, and China to diversify its production ...

External regulatory, economic, and technological forces ensured that the story of 2025 for CDMO marketers was turbulence. How ...

Halozyme Therapeutics Inc. and Skye Bioscience Inc. have entered a non-exclusive global collaboration and license agreement.

As previously announced l a st year, Fujifilm Irvine Scientific Inc. has officially changed its legal name to Fujifilm ...